baber/WOPTO huggingface dataset:
Patent AU-659875-B2 (AU)
Title: Device for detecting synchronisation on digital phase-locked loop
Inventor: LAFON JEAN-LUC
IPC: H04L7/033
Filed: 1992-09-29
Granted: 1995-06-01
Abstract: This phase lock detection device for a digital phase-locked loop is such that the phase-locked loop (1) including a detector of phase disparity between the said incoming signal and the said outgoing signal, and the output signal from this phase-disparity detector exhibiting transitions of a first type coinciding with the transitions of a given type of the outgoing signal, and transitions of a second type coinciding with the transitions of a given type of the incoming signal, this device includes, in order to carry out the said phase-lock detection, phase-lock detection means (5) themselves including means for carrying out sampling of the output signal from the phase detector, by those of the transitions of the outgoing signal which are of opposite type to the said given type, means (50) for storing groups of consecutive samples, equal to at least 3 in number, and means (54) for detecting the instant at which, for the first time, two at least of the said samples do not have the same logic level. 
<IMAGE>
Patent AU-724502-B2 (AU)
Title: Polymer powders redispersible in aqueous solution
Inventor: BREITENBACH JORG
IPC: A61K47/32
Filed: 1997-04-24
Granted: 2000-09-21
Abstract: Polymer powders redispersible in aqueous solution, their use in cosmetic, pharmaceutical or crop protection formulations and a process for preparing polymer powders redispersible in aqueous solution comprising copolymers carrying free acid or base groups and, if appropriate, auxiliaries, which comprises adjusting the pH of the dispersion prior to drying by the addition of at least one buffer system to a pH of from 2.0 to 6.5 in the case of copolymers carrying free acid groups or a pH of from pH 7.5 to 12 in the case of copolymers carrying free base groups.
Patent AU-699363-B2 (AU)
Title: Method for determining the lysine content of seeds
Inventor: MORO GLOVERSON
IPC: C07K16/16
Filed: 1995-07-13
Granted: 1998-12-03
Abstract: Seed lysine is detected by an immunoassay in which anti-EF antibody binds seed protein. Seed EF concentration is highly correlated with seed lysine content.
Patent AU-625899-B2 (AU)
Title: Articles having permanent indicia thereon
Inventor: CHAN CHI-MING
IPC: B41M1/30
Filed: 1989-03-21
Granted: 1992-07-16
Abstract: Permanent indicia can be applied to a surface consisting of a polymeric composition having a specific gravity less than about 1.35, and having a roughness average of at least about 2  mu m and an average peak width of less than about 200  mu m. The indicia are resistant to organic solvents, smearing and abrasion without a permatizing step. The surface can be, for example, the polymeric surface of a marker sleeve, preferably a heat-recoverable marker sleeve.
Patent AU-765569-B2 (AU)
Title: Water-soluble pro-drugs of propofol
Inventor: HENDLER SHELDON S
IPC: C07F9/12
Filed: 1999-05-07
Granted: 2003-09-25
Abstract: This invention provides esters of propofol (2,6,-diisoprophenol). The propofol esters are soluble in water and metabolize rapidly to propofol in the body. The propofol esters are useful as pro-drugs for the same indications as propofol. This invention also provides methods of treating neurodegenerative diseases by administering as effective amount of propofol.
Patent AU-641362-B2 (AU)
Title: New photosensitizing agents
Inventor: PANDEY RAVINDRA K
IPC: C07D487/22
Filed: 1989-07-19
Granted: 1993-09-23
Abstract: Pyropheophorbide compounds are injected into a host and accumulate in tumor tissue to a higher degree than surrounding normal tissues. When the pyropheophorbide compounds are exposed to a particular wavelength of light the compounds become cytotoxic and destroy the tumor or diseased tissue without causing irreversible normal tissue damage. The pyropheophorbide compounds have shown improved results as compared to drugs currently used in photodynamic therapy. Further, they absorb light further in the red, optimizing tissue penetration and are retained in the skin for short time periods relative to other drugs used in photodynamic therapy.
Patent AU-617866-B2 (AU)
Title: Process for the dyeing and printing of cellulose fibers in the absence of alkali or reducing agents
Inventor: STERNBERGER KLAUS
IPC: D06P1/52
Filed: 1989-09-15
Granted: 1991-12-05
Abstract: Process for the alkali-free dyeing and printing of cellulose fibres with reactive dyes, direct dyes, acid dyes, water-soluble sulphur dyes or sulphur vat dyes, wherein the textile material to be dyed is pretreated with a wetting agent and a reaction product of an epihalogenohydrin and ammonia or an amine of the formula 
<IMAGE>
 where A is hydrogen, alkyl having 1 to 5 carbon atoms or hydroxyalkyl having 1 to 5 carbon atoms, R is alkyl having 1 to 5 carbon atoms, hydroxyalkyl having 1 to 5 carbon atoms, a group of the formula 
<IMAGE>
 (n = 0 to 5), a group of the formula 
<IMAGE>
 (X = oxygen or sulphur) (n = 0 to 5), or R and A together are 
<IMAGE>
 then dyed with the dyes mentioned in a conventional manner but without alkali, and the dyeing is finished by rinsing, soaping and drying.
Patent AU-724720-B2 (AU)
Title: Antioxidant derived from lentil and its preparation and uses
Inventor: RONZIO ROBERT A
IPC: A23L1/30
Filed: 1997-08-26
Granted: 2000-09-28
Abstract: The preparation of extracts of seed coats of lentil (Lens esculenta) as a representative member of the Leguminosae, extracted with a range of volatile solvents, such as methanol, acetone, singly or a mixture with water, and food solvents, such as ethyl acetate and ethanol, to yield such extracts that are water-soluble, which contain a rich mixture of condensed tannins (procyanidins and prodciphinidin as glycosides), together with a flavanone (luteolin) and flavonols (quercetin, kaempferol) and phenolic acids (ferulic acid, protocatechuic acid, caffeic acid) and which possess the ability to quench organic free radicals, to scavenge superoxide, to inhibit the oxidation of water soluble nutrients such as vitamin C, as well as the oxidation of fat-soluble nutrients such as essential fatty acids, and to limit damage due to oxidants linked to inflammatory conditions, and to inhibit certain cells responsible for inflammation, is disclosed.
Patent AU-700659-B2 (AU)
Title: Support of multiplicity of radio interfaces over an interface between base station system and a mobile switch
Inventor: DURCHMAN ELINA
IPC: H04W88/10
Filed: 1996-01-11
Granted: 1999-01-14
Abstract: In mobile radio systems, it may be necessary to support multiple radio interfaces within a single mobile radio network. To support these multiple radio interfaces, it may be necessary to support even multiple signalling protocols within a single interface between a base station controller and a mobile switch, when base stations supporting different radio interfaces are connected via a common base station controller to the mobile switch. The mobile switch and the base station controller must be capable of recognizing to which signalling protocol a message transfer in the single interface belongs to. The messages transferred in the single interface are provided with a discrimination parameter which can be used to discriminate between the messages belonging to different radio interfaces and signalling protocols.
Patent AU-693989-B2 (AU)
Title: Basic oxazoline-amide derivatives of GE 2270 and GE 2270-like antibiotics
Inventor: LOCIURO SERGIO
IPC: C07K5/078
Filed: 1996-02-01
Granted: 1998-07-09
Abstract: PCT No. PCT/EP96/00425 Sec. 371 Date Jul. 31, 1997 Sec. 102(e) Date Jul. 31, 1997 PCT Filed Feb. 1, 1996 PCT Pub. No. WO96/24608 PCT Pub. Date Aug. 15, 1996The present invention refers to basic oxazoline-amide derivatives of GE 2270 and GE 2270-like antibiotics of general formula (I), wherein the group GE represents the antibiotic core molecule. The amide derivatives of antibiotic GE 2270 of formula (I) are antimicrobial agents mainly active against gram positive bacteria.    <IMAGE>  (I)
Patent AU-675235-B2 (AU)
Title: Photoactivation of proteins for conjugation purposes
Inventor: SYKES THOMAS R
IPC: C07K1/13
Filed: 1993-07-06
Granted: 1997-01-30
Abstract: A protein containing one or more disulfide bonds, e.g., an antibody, is subjected to ultraviolet radiation to reduce one or more such bonds to reactive sulfhydryl groups; the resulting photoactivated protein is reacted with other chemical entity which is reactive with sulfhydryl, such as certain radiometals, chelating agents, drugs and toxins, so as to obtain a conjugate useful in, e.g., in vitro diagnosis, in vivo imaging, and therapy.
Patent AU-638229-B2 (AU)
Title: A method of freezing red blood cells
IPC: A61K35/18
Filed: 1990-01-31
Granted: 1993-06-24
Abstract: A method of freezing a standard donor unit of red blood cells such that it can be stored for long periods and subsequently recovered in a form pure enough for transfusion purposes uses red blood cells separated from plasma and platelets, as obtainable by centrifuging whole blood. The red blood cells are treated so that they have a Packed Cell Volume of not less that 90% and are added to a freezing bag (13) containing HES solution such that the ratio of HES/red blood cells is no more that 7% (preferably 6%) w/v. The bag (13) is placed in a freezing frame (20, 21), which is adapted to maintain the thickness of the contents of the bag constant, and the frame is placed in liquid nitrogen. <IMAGE>
Patent AU-635004-B2 (AU)
Title: Low oil corrugated potato chip
IPC: A23L19/18
Filed: 1990-02-01
Granted: 1993-03-11
Abstract: Low oil potato chips having corrugated cross-sectional configurations wherein the value of amplitude/period ranges from about 0.35 to about 0.50 and wherein ridges on one face of the corrugated chip are in-phase with grooves on the opposing face of the corrugated chip.
Patent AU-629629-B2 (AU)
Title: New unsaturated derivatives of 2,6-amino-heptanedioic acid, their preparation process and their application as medicaments
Inventor: AGOURIDAS CONSTANTIN
IPC: A61K31/235
Filed: 1990-04-18
Granted: 1992-10-08
Abstract: Novel derivatives of formula <IMAGE>  in which,  - the dotted lines represent an optional endo or exo double bond, - Y represents a (C2-18) alkyl, alkenyl or alkynyl or a (C1-18) alkyl substituted by one or several halogens, - X, X' and X1 represent hydrogen, an (-> C8) alkyl, alkenyl or alkynyl, an (-> C14) aryl, an (-> C18) aralkyl or an acyl derived from a fatty acid and/or an amino acid, and either n and/or n1 represents 1 and R and/or R1 represents an amino radical or an amino acid radical, or n and/or n1 represent 2 and R and R1 represent hydrogen, an (C1-8) alkyl or an (-> C14) aryl or an (-> C18) arylalkyl or a <IMAGE> radical,  in which R2 represents a (C1-8) alkyl or an (-> C14) aryl, as well as their salts with acids or bases, a process for their preparation, their application as drugs and the compositions containing them.
Patent AU-673872-B2 (AU)
Title: Warp and weft fabric based on predominantly untwisted multifilament yarn and method for producing same
Inventor: AUCAGNE JEAN
IPC: D06C15/02
Filed: 1993-11-30
Granted: 1996-11-28
Abstract: A woven fabric to be used in formation of a composite material includes multifilament warp and weft threads. Each of the warp threads and the weft threads have a total weight less than 80% of the weight of the fabric. The woven warp and weft threads have O twist/m and a torsion no greater than an original torsion of the threads before weaving. Each woven warp and weft thread has a width over the entire length thereof that is greater than or equal to an original width before weaving. The fabric is woven to have a given weight per unit area and a fiber volume ratio that is approximately constant throughout the fabric and that is satisfactory for use of the fabric in a composite material. The warp and weft threads of a yarn count that is greater than a yarn count traditionally used to achieve the fiber volume ratio for the given weight per unit area.
Patent AU-585598-B2 (AU)
Title: Reinforced polymeric component and method of manufacture
Inventor: RAUSCH DOYLE W
IPC: B29D29/08
Filed: 1986-04-15
Granted: 1989-06-22
Abstract: A reinforced belt assembly or construction which utilizes a reinforcing material comprised of a reinforcing member portion possessing a high Young's modulus discontinuous throughout the length of the reinforcing material and a carrier member portion extending the length of the reinforcing material. The carrier member portion facilitates transport and winding of the reinforcing material about a forming mandel during manufacture and facilitates cutting of the belt assembly from the cured reinforced sleeve material such that the Young's modulus member does not emerge from the cut sidewalls of the belt assembly.
Patent AU-626427-B2 (AU)
Title: Heterocyclic amines having central nervous system activity
Inventor: MOON MALCOLM W
IPC: C07D471/06
Filed: 1990-05-15
Granted: 1992-07-30
Abstract: Tricyclic nitrogen containing compounds, having central nervous system activity of structural formula (I) and pharmaceutically acceptable salts thereof, wherein R1, R2, and R3 are independently hydrogen, C1-6 alkyl, alkenyl, or alkynyl, C3-10 cycloalkyl, or R1 and R2 are joined to form a C3-7 cyclic amine which can contain additional heteroatoms; X is hydrogen, C1-6 alkyl, halogen, hydroxy, alkoxy, cyano, carboxamide, carboxyl, or carboalkoxyl; A is SO2, N, CH, CH2, CHCH3, C=O, C=S, C-SCH3, C=NH, C-NH2, C-NHCH3, C-NHCOOCH3, or C-NHCN; B is CH2, CH, C=O, N, NH or N-CH3; n is 0 or 1; and D is CH, CH2, C=O, O, N, NH or N-CH3. These new compounds are suitable for treating schizophrenia, Parkinson's disease, anxiety, depression or as compounds for lowering blood pressure in animal or human hosts.
Patent AU-634555-B2 (AU)
Title: Rod anchoring device
IPC: F16B33/04
Filed: 1990-06-25
Granted: 1993-02-25
Abstract: PCT No. PCT/EP90/01132 Sec. 371 Date Dec. 4, 1991 Sec. 102(e) Date Dec. 4, 1991 PCT Filed Jun. 25, 1990 PCT Pub. No. WO91/00433 PCT Pub. Date Jan. 10, 1991.The invention relates to a bar anchor arrangement for bars subject to tensile stress, whereby the bar anchor (1) consists of an anchor body with a bore provided with an internal thread (5) for screwing in a tension bar (8) provided with an external thread (9) as well as of two parallel eye plates (3) adjoining the anchor body to accomodate an eye bar (10). A smooth tolerance compensating section (6 and 7) is provided on at least one side of the internal thread (5). The length of the external thread (9) of the tension bar (8) essentially corresponds to the minimum screw-in length of the tension bar plus the length of a tolerance compensating section. The length of the internal thread (5) is greater than the minimum screw-in length of the tension bar.
Patent AU-647034-B2 (AU)
Title: Novel diamine compounds and cerebral protective drugs containing the same
Inventor: SATO SEIICHI
IPC: C07C211/49
Filed: 1990-07-30
Granted: 1994-03-17
Abstract: The present invention provides a diamine compound of formula (I) or an acid addition salt thereof: <CHEM> wherein R1, R2, R3, R4, R5 and R6 are the same or different from each other and represent individually a hydrogen atom, halogen atom, hydroxyl group, lower alkyl group, lower alkoxy group, lower acyloxy group, lower alkoxycarbonyloxy group, lower alkylsulfonyloxy group or am amino group, among which the lower alkyl group and lower alkoxy group may be substituted by a halogen atom or a phenyl group; R7 and R8 are the same or different from each other and represent individually a lower alkyl group or the two bind to each other to represent an alkylene group having 1 to 4 carbon atoms; A and A' are the same or different from each other and represent individually a single bond, -O-, -NH-, -NHCO->, -CONH->, -NHCOO->, NHCONH-, -SO2NH-> or -COS-> (here, the symbol '->' denotes a bond to Y or Y'), Y and Y' are the same or different from each other and represent a lower alkylene group or lower alkenylene group; and cerebral protective drugs containing such compound. The diamine compounds (I) or its acid addition salts have an excellent cerebral protective action, are very safe, and exhibit a strong action when even orally administered, and therefore, medicines containing such compounds are effective for treating disorders caused by cerebral hemorrhage, cerebral infarction, subarachnoid hemorrhage, transient ischemic attack, cerebrovascular disorders and the like, or preventing progress of such disorders.
Patent AU-625140-B2 (AU)
Title: A liquid dispensing system and packaging apparatus which includes such a system
Inventor: QUINN THOMAS PATRICK
IPC: B65B31/00
Filed: 1990-08-16
Granted: 1992-07-02
Abstract: A liquid dispensing system and a packaging apparatus which includes such a system has a chamber 6 of a chryogenic vessel 2 containing a reservoir of liquid gas 1 (such as nitrogen, oxygen or argon) which is to be dispensed in doses 26 through an outlet port 12 which is in constant communication with a sub-chamber 17. The sub-chamber 17 is part of a piston 16 and cylinder 15 device in which the piston is reciprocated by means 21 and 24 to expand and contract the sub-chamber. When the sub-chamber 17 is expanded, liquid gas enters from the reservoir 1 through flow ports 18 which are closed by the piston 16 during contraction of the sub-chamber to dispense a dose 26. Mounted beneath the outlet port 12 is a tubular skirt 25 having internal passages 30 through which purging gas is directed into the region 29 adjacent to the outlet port 12. The region 29 is purged of air to alleviate ice build-up at the outlet port 12. The purging gas liquifies at a temperature not greater than the temperature of the liquid gas at the outlet port and provides a back-pressure at the outlet port to restrain flow of liquid gas therethrough prior to the contraction of the sub-chamber 17 to dispense a dose. The doses 26 are dispensed into open topped containers 34 that are moved successively beneath the outlet port 12 and means 50 is provided for sensing the containers and controlling the devices 21 and 24 to maintain synchronisation between the dispensing and the movement of the containers.
Patent AU-601699-B2 (AU)
Title: Mass transfer extraction of liquids from solids
Inventor: RICE WAYNE K
IPC: C11B1/10
Filed: 1986-09-05
Granted: 1990-09-20
Abstract: An extraction process comprises contacting a material to be extracted with an extracting fluid at elevated pressure within a defined space, and separating the extracting fluid and extract, as a mass, from the extracted material while reducing the volume of the defined space and while maintaining the elevated pressure within the defined space. Apparatus for carrying out the process is adapted to separate the extracting fluid and the extract, as a mass, from the extracted material, while maintaining elevated pressure and reducing the volume at the point of separation.
Patent AU-745916-B2 (AU)
Title: Systems for percutaneous bone and spinal stabilization, fixation and repair
Inventor: BEYAR MORDECHAY
IPC: G01L7/16
Filed: 1998-03-06
Granted: 2002-04-11
Abstract: An intervertebral spacer suitable for fixating a spine, including: a plastically-deformable surface, configured for increasing in diameter by said plastic deformation; and a plurality of protrusions formed of said surface, axially displaced along a long axis of said surface and adapted to stabilize said spacer against bone, when said spacer is radially expanded.
Patent AU-749529-B2 (AU)
Title: Model for chronic cerebral inflammation by intracerebral injection of polynucleotide
Inventor: MORRIS CHRISTOPHER MILES
IPC: G01N33/50
Filed: 1998-03-26
Granted: 2002-06-27
Abstract: A method of producing a non-human mammalian model of chronic cerebral inflammation is disclosed. The method comprises introducing into the mammal's brain a polynucleotide that does not encode amyloid precursor protein (APP). Applicants have discovered that APP expression is not necessary to mimic the symptoms of human neurodegenerative diseases. The mammalian models mimic in an in vivo system some of the physical manifestations of diseases of the central nervous system, such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and encephalopathies. The models are useful in screening putative prophylactic and therapeutic compositions for addressing symptoms of chronic cerebral inflammation.
Patent AU-639058-B2 (AU)
Title: Method and compositions for stimulating vesicular-arbuscular mycorrhizal fungi
IPC: A01N63/30
Filed: 1990-11-19
Granted: 1993-07-15
Abstract: A method and compositions for stimulating the growth of vesicular-arbuscular mycorrhizal fungi alone or in the presence of a plant material using isoflavonoid compounds is described. The isoflavonoids are preferably of the formula:   <IMAGE>   wherein R1, R2 and R3 are selected from the group consisting of hydrogen, hydroxyl and alkoxy, particularly methoxy.
Patent AU-644410-B2 (AU)
Title: Ball-cock
Inventor: OTTENS JAN
IPC: F16K27/06
Filed: 1991-03-08
Granted: 1993-12-09
Abstract: Ball-cock made of plastic parts with a spherical shut-off element (28) in a housing (4) with at first housing end (8a) a nesting place for a sealing ring (62) and at the other end (8b) an end flange (18) with also a nesting place for a sealing ring (62), said end flange (18) having a radially projecting peripheral rib (16) snapping into a peripheral groove (14) near the second housing end (8b) in the inside wall thereof, housing flange (4) and end flange (18) being each provided with a short cylindrical end stub (12, 22 respectively) sealingly accommodated in an outer housing (6) of which the inside end wall (52) determines a nesting place for one of the sealing rings (62), and which at the other end is shut off by an end flange (58) determining a nesting place for the other sealing ring (66). <IMAGE>
Patent AU-679770-B2 (AU)
Title: Process for making HIV protease inhibitors
Inventor: ASKIN DAVID
IPC: C07D413/06
Filed: 1994-07-11
Granted: 1997-07-10
Abstract: <CHEM>   Intermediates of structural formula (A) can be made by reacting a primary or secondary amine with glycidol or an activated derivative thereof. The process and intermediates are useful for synthesizing HIV protease inhibitor compounds, particularly L-735,524. <CHEM>
Patent AU-774309-B2 (AU)
Title: DNA immunization against chlamydia infection
Inventor: BRUNHAM ROBERT C
IPC: C12N15/54
Filed: 2000-09-21
Granted: 2004-06-24
Abstract: Nucleic acid, including DNA, immunization is used to generate a protective immune response in a host, including humans, to a serine-threonine kinase (STK) of a strain of Chlamydia. A non-replicating vector, including a plasmid vector, contains a nucleotide sequence encoding a STK or a fragment of the STK that generates antibodies that specifically react with STK and a promoter sequence operatively coupled to the first nucleotide sequence for expression of the STK in the host. The non-replicating vector may be formulated with a pharmaceutically-acceptable carrier for in vivo administration to the host.
Patent AU-640009-B2 (AU)
Title: Low moisture fat-containing foods such as potato chips having less waxiness and improved flavor display
IPC: A23L5/10
Filed: 1991-04-08
Granted: 1993-08-12
Abstract: Reduced calorie, low moisture fat-containing foods such as potato chips having less waxiness and improved flavor display are disclosed. These benefits are typically obtained by applying to the surface of the potato chip, or other food, fat compositions having certain thixotropic areas that correlate to reduced waxiness impressions. These fat compositions comprise a nondigestible fat component, and optionally a digestible triglyceride fat or oil. The nondigestible fat component comprises a nondigestible oil and certain solid polyol fatty acid polyesters having ester groups consisting essentially of long chain (C14 or higher) saturated fatty acid radicals that bind such liquid oils and thus control or prevent passive oil loss.